Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz launches generic version of Pulmicort Respules®
Princeton, New Jersey, July 28, 2015
Sandoz today announced the US market introduction of its budesonide inhalation suspension, a generic version of Pulmicort Respules® (budesonide) inhalation suspension 1 mg strength by AstraZeneca LP.
Sandoz launches Breathe Africa program to improve asthma diagnosis, treatment and patient outcomes in Zambia
Holzkirchen, Germany, July 24, 2015
Sandoz today announced the launch of Breathe Africa, a respiratory health program aimed at improving the diagnosis and treatment of asthma through sharing medical expertise and donating medicines.
Court ruling paves the way for launch of Sandoz’s Zarxio as first US biosimilar
Holzkirchen, Germany, July 22, 2015
The US Court of Appeals for the Federal Circuit issued a ruling on July 21 that paves the way for Sandoz to launch Zarxio (filgrastim) after September 2, as the first US biosimilar.
Novartis announces second quarter results
Basel, July 21, 2015
Novartis delivered solid performance and strong pipeline progress with major approvals and key launches.
Sandoz launches the Balans programme in Central and Eastern Europe to promote healthier living
July 09, 2015
Sandoz is launching the Balans programme in a number of Central and Eastern European countries, including Slovenia, Ukraine, Kazakhstan, Latvia, Serbia and Romania, in addition to Russia and Turkey.